• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Impact of PET-CT status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplant

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    35586966.pdf
    Size:
    2.544Mb
    Format:
    PDF
    Download
    Authors
    Eyre, T. A.
    Barrington, S. F.
    Okosun, J.
    Abamba, C.
    Pearce, R. M.
    Lee, J.
    Carpenter, B.
    Crawley, C. R.
    Bloor, Adrian
    Gilleece, M.
    Nicholson, E.
    Shah, N.
    Orchard, K.
    Malladi, R.
    Townsend, W. M.
    Show allShow less
    Affiliation
    Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    The optimum management approach for patients with relapsed or refractory (R/R) follicular lymphoma (FL) remains uncertain. Autologous stem cell transplantation (autoSCT) is considered a standard option in suitable, younger patients with relapsed FL. AutoSCT is associated with very durable remissions in a minority but also significant, wellestablished toxicities. Although PET status pre-autoSCT is established in diffuse large B-cell lymphoma and Hodgkin lymphoma, no data exists in FL. We describe survival outcomes according to pre-autoSCT PET status according to Lugano criteria (complete metabolic remission (CMR) vs non-CMR) in 172 R/R FL patients within a national, multicentre, retrospective BSBMTCT registry study. Median number of prior lines pre-autoSCT was 3 (range 1-6). Median follow-up post-autoSCT was 27 months (range 3-70). Median progression-free survival (PFS) for all patients post-autoSCT was 28 months (interquartile range 23-36). There was no interaction between age at autoSCT, sex, number of months since last relapse, Karnofsky performance status or comorbidity index (HCT-CI) and achieving CMR pre-autoSCT. Superior progression-free survival was observed in 115 (67%) patients obtaining CMR versus 57 (33%) non-CMR patients (3-year PFS 50% vs. 22%, p=0.011) and by Deauville score pre-autoSCT (continuous variable 1-5, hazard ratio (HR) 1.32, p=0.049). PETstatus was independently associated with PFS (non-CMR HR 2.02, p=0.003), overall survival (non-CMR HR 3.08, p=0.010) and risk for relapse (non-CMR HR 1.64, p=0.046) post autoSCT by multivariable analysis. Our data suggests PET-status pre-autoSCT provides clear prognostic value and may help improve patient selection for autoSCT.
    Citation
    Eyre TA, Barrington SF, Okosun J, Abamba C, Pearce RM, Lee J, et al. Impact of PET-CT status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplant. Haematologica. Ferrata Storti Foundation (Haematologica); 2022. 
    Journal
    Haematologica
    URI
    http://hdl.handle.net/10541/625321
    DOI
    10.3324/haematol.2021.280287
    PubMed ID
    35586966
    Additional Links
    https://dx.doi.org/10.3324/haematol.2021.280287
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.3324/haematol.2021.280287
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • [Follicular lymphoma: first - line selection criteria of treatment].
    • Authors: Nesterova ES, Kravchenko SK, Kovrigina AM, Gemdzhian EG, Plastinina LV, Babaeva FE, Obukhova TN, Magomedova AU, Gaponova TV, Kremenetskaya AM, Vorobyev AI
    • Issue date: 2019 Aug 15
    • Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
    • Authors: Evens AM, Vanderplas A, LaCasce AS, Crosby AL, Nademanee AP, Kaminski MS, Abel GA, Millenson M, Czuczman MS, Rodriguez MA, Niland J, Zelenetz AD, Gordon LI, Friedberg JW
    • Issue date: 2013 Oct 15
    • Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experience.
    • Authors: Roerden M, Sökler M, Kanz L, Bethge W, Vogel W, Walz JS
    • Issue date: 2020 Feb
    • Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).
    • Authors: Dietrich S, Boumendil A, Finel H, Avivi I, Volin L, Cornelissen J, Jarosinska RJ, Schmid C, Finke J, Stevens WB, Schouten HC, Kaufmann M, Sebban C, Trneny M, Kobbe G, Fornecker LM, Schetelig J, Kanfer E, Heinicke T, Pfreundschuh M, Diez-Martin JL, Bordessoule D, Robinson S, Dreger P
    • Issue date: 2014 May
    • Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†.
    • Authors: Robinson SP, Boumendil A, Finel H, Schouten H, Ehninger G, Maertens J, Crawley C, Rambaldi A, Russell N, Anders W, Blaise D, Yakoub-Agha I, Ganser A, Castagna L, Volin L, Cahn JY, Montoto S, Dreger P
    • Issue date: 2016 Jun 1
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.